Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

September 17, 2014

Research sheds light on cognitive losses seen with chemotherapy, autoimmune diseases

  • Misc. Research Reports
    /
Sept 17, 2014 Brain inflammation can rapidly disrupt our ability to retrieve complex memories of similar but distinct experiences, according to UC…
Misc. Research Reports

September 17, 2014

A biologic drug targeting the granulocyte-macrophage colony stimulating factor (GM-CSF) was safe and showed hints of activity against brain lesions in multiple sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
Published: Sep 14, 2014 By John Gever, Managing Editor, MedPage Today Action Points Note that this study was published as an…
MS Research Study and Reports

September 17, 2014

Generic Copaxone for MS Passes Clinical Test

  • MS Drug Therapies
    /
By John Gever, Managing Editor, MedPage Today BOSTON — A copycat version of the multiple sclerosis (MS) drug Copaxone, known generically…
MS Drug Therapies

September 17, 2014

Myelin Measure in MS Tracks Patient Disability

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Myelin Repair
    /
September 11, 2014 By John Gever, Managing Editor, MedPage Today BOSTON — Whole-brain measures of myelin water fraction (MWF) — reflecting…
MS Research Study and Reports

September 17, 2014

ACTRIMS-ECTRIMS Conference Coverage – from MS World.org

  • Misc. Research Reports
    /
  • MS Educational Programs
    /
  • MS Genetic Research
    /
  • MS Research Study and Reports
    /
Watch Coverage Now View Newsletter on: ACTRIMS-ECTRIMS Conference Coverage =========================================================== ~~~~~~~~~~~~~~~~~~~~  Keep CURRENT and up to date, with MS News and Information…
Misc. Research Reports

September 16, 2014

The Johns Hopkins Multiple Sclerosis Center is the recipient of one of 22 research grants offered to find solutions for Progressive MS

  • MS Research Study and Reports
    /
The Johns Hopkins Multiple Sclerosis Center is the recipient of one of 22 research grants offered to investigators in nine countries by…
MS Research Study and Reports

September 16, 2014

AbbVie, Biogen to file for FDA approval of MS drug (daclizumab), next year

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
September 15, 2014 Phase-III results of the AbbVie-Biogen Idec experimental multiple sclerosis shot Zinbryta (daclizumab) indicate the drug bests Biogen’s…
MS Drug Therapies

September 16, 2014

Healthy’ Diets Don’t Seem to Reduce MS Risk

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Nutrition
    /
Published: Sep 15, 2014 By John Gever, Managing Editor, MedPage Today Action Points Note that this study was published as an…
MS Research Study and Reports

September 16, 2014

Life from a Sitting Position – an MS patient’s story

  • An MS Patients Story
    /
by Richard M. Cohen on September 13, 2014 in JOURNEYMAN We have just about done this subject to death. Lots of attitudes and ap[p[roaches. Your…
An MS Patients Story

September 15, 2014

Sanofi (France), Genzyme’s Corporation Report Positive New Data From …

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
9/11/2014  At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies…
MS Drug Therapies

Categories

Latest Blog Posts